Researchers have successfully utilized postnatal single nucleotide polymorphism (SNP) microarray analysis to definitively distinguish between mosaicism and chimerism in a male infant who was prenatally diagnosed with a 46,XX/46,XY karyotype. The study, involving a child now four years and seven months old, provides critical insights into the diagnostic pathway for sex chromosome anomalies that present during prenatal screening. While the coexistence of 46,XX and 46,XY cell lines in amniotic fluid can be clinically ambiguous, this case underscores the utility of combining conventional cytogenetics with advanced molecular diagnostics to achieve a precise diagnosis. The patient, who remains phenotypically normal with male genitalia, serves as only the second documented case of prenatally diagnosed and postnatally confirmed 46,XX/46,XY mosaicism in a patient with a standard male phenotype, offering a clearer picture for counseling families facing similar prenatal findings.
The finding of a mixture of 46,XX and 46,XY cells in cultured amniotic fluid is not unprecedented, with reported frequencies of approximately 1.5 per 1,000 samples. In the vast majority of these clinical situations, the mixture arises from maternal cell contamination (MCC) occurring during the amniocentesis procedure itself, particularly in cases involving bloody samples. However, distinguishing between MCC and genuine biological phenomena like true fetal chimerism or mosaicism is a long-standing challenge in clinical cytogenetics. Chimerism refers to the presence of cell lines derived from different zygotes, whereas mosaicism is defined as the existence of more than one cell line derived from a single zygote. Conventional karyotyping is often insufficient to differentiate these conditions because it can identify multiple cell lines but cannot track their parental origins.
In the case presented, a 37-year-old nulliparous woman underwent amniocentesis at 19 weeks of gestation due to advanced maternal age. Initial chromosome analysis of the fluid sample revealed a mixture of 46,XX and 46,XY cell lines. Throughout the pregnancy, prenatal ultrasound examinations consistently showed normal male genitalia and no other structural abnormalities. The infant was delivered vaginally at 38 and five-sevenths weeks of gestation with a birth weight of 3,170 grams and standard Apgar scores. Physical examination at birth confirmed normal male external genitalia, with normally palpable testes in the scrotum and an anogenital distance of 2 centimeters, with subsequent imaging by abdominal ultrasound and magnetic resonance imaging (MRI) confirming normal internal male genitalia.
Postnatal investigation was extensive, utilizing a multi-layered diagnostic approach to characterize the genetic landscape. Peripheral blood lymphocytes were cultured and analyzed via conventional karyotyping, which yielded a 46,XX[28]/46,XY[22] mosaicism. To confirm the presence of the Y chromosome, polymerase chain reaction (PCR) amplification for the sex-determining region Y (SRY) gene was performed, resulting in a positive signal. Beyond traditional karyotyping, the team deployed a high-resolution CytoScan 750 K SNP array, which includes approximately 750,000 markers. This array allowed for a detailed copy number analysis and heterozygosity profiling. The copy number (CN) profile of the sex chromosomes revealed a consistent finding of mosaicism, with a CN of 1.44 for the X chromosome and a CN of 0.56 for the Y chromosome, providing a quantitative validation of the cell population ratios observed in the karyotype.
Further molecular granularity was achieved through short tandem repeat (STR) analysis, which evaluated 15 autosomal markers. This technique proved essential for confirming that both cell lines shared the same parental origin, effectively ruling out tetragametic chimerism, which would require the presence of two distinct paternal and maternal allele patterns. The STR genotyping identified a biallelic inheritance pattern consistent with a single zygote origin. Furthermore, the B-allele frequency (BAF) plot generated by the SNP array demonstrated an absence of heterozygosity (AOH) across the entire X chromosome, with an exclusive maternal inheritance of the markers. This pattern is strongly suggestive of a single genetic origin for the X chromosomes and argues against the presence of two genetically distinct zygotes, reinforcing the diagnosis of mosaicism over chimerism.
The study also incorporated interphase fluorescence in situ hybridization (FISH) to analyze tissues derived from different embryonic germ layers, including urine-derived cells and buccal epithelial cells. Interestingly, the FISH results showed an XY predominance in these tissues, in contrast to the findings from amniocytes and leukocytes. Because the mosaicism was identified across tissues originating from both ectodermal and mesodermal germ layers, the research team inferred that the underlying genetic event must have occurred at a very early stage of embryogenesis, prior to the differentiation of these germ layers.
Regarding the mechanistic origins, the research team evaluated two primary theoretical models. One model proposes that a nondisjunction event during meiosis II in oogenesis results in a 24,XX oocyte. Fertilization by a normal 23,Y sperm then produces a 47,XXY zygote. During the first postzygotic mitotic division, an error such as anaphase lag could result in the loss of one X chromosome in one daughter cell line and the Y chromosome in the other, establishing the 46,XX/46,XY mosaicism. A second, alternative mechanism suggests a postzygotic nondisjunction in a 46,XY embryo where both X and Y chromosomes are simultaneously involved in a mitotic error, leading to a 46,XX/46,YY cell line, with the 46,YY line subsequently becoming nonviable. The researchers concluded that the former mechanism—meiotic II nondisjunction followed by postzygotic mitotic rescue—is far more plausible given the probabilistic likelihood of a single chromosome loss event compared to the highly improbable simultaneous double-segregation error required by the second model.
This case highlights the growing power of SNP microarrays in clinical practice. Unlike earlier eras of diagnostic medicine where the distinction between mosaicism and chimerism was often speculative, the ability to utilize allele counts and AOH detection provides a definitive diagnostic pathway. The absence of additional AOH regions on autosomal chromosomes in this patient further supported the lack of uniparental disomy or other deleterious genomic events, which can sometimes be associated with mosaicism and increase the risk of imprinting-related diseases. By successfully excluding these conditions, the clinicians were able to provide a more accurate prognosis for the parents.
Despite the successful identification of the mosaic mechanism, the authors acknowledge limitations, such as the unavailability of CEP18 probes in the AneuVysion set, which would have served as an internal ploidy control to absolutely exclude tetraploid cells. Nevertheless, the concordant data from karyotyping, SNP array, STR analysis, and FISH across multiple tissues provide a robust evidence base for the diagnosis. The phenotypic presentation of the patient—a healthy child now in his fifth year—demonstrates that even when prenatal screening detects sex chromosome mosaicism, the fetus can achieve a favorable outcome without overt genital or congenital abnormalities.
The study concludes that when clinicians encounter an XX/XY mixture during prenatal diagnosis, it is imperative to move beyond conventional karyotyping to utilize advanced molecular tools. Detailed prenatal ultrasound for the assessment of external and internal genitalia remains a cornerstone for predicting prognosis, but molecular confirmation provides the necessary evidence to guide long-term management. As more cases are evaluated, the medical community will gain a better understanding of the spectrum of 46,XX/46,XY outcomes. Given that these patients might still manifest subtle variations in secondary sexual development or fertility, close, long-term clinical follow-up is indicated to ensure ongoing health and appropriate developmental care.
Subject of Research: Diagnostic analysis and mechanistic investigation of 46,XX/46,XY chromosomal mosaicism in a phenotypically normal male.
Article Title: Using SNP microarray to distinguish mosaicism from chimerism in a phenotypically normal male newborn with prenatal 46,XX/46,XY karyotype
Article References: Chen, J.-C., Su, P.-H., Jong, Y.-J., Huang, P.-C., Cheng, S.-Y., & Lin, Y.-H. (2026). Using SNP microarray to distinguish mosaicism from chimerism in a phenotypically normal male newborn with prenatal 46,XX/46,XY karyotype. Molecular Cytogenetics, 19(1), Article 35. https://doi.org/10.1186/s13039-026-00776-1
Image Credits: AI Generated
DOI: 10.1186/s13039-026-00776-1
Keywords: 46,XX/46,XY mosaicism, SNP microarray, prenatal diagnosis, postzygotic mitotic rescue, genetic counseling, chimerism, cytogenetics, sex chromosome anomalies, SRY gene, microsatellite genotyping, maternal cell contamination, clinical genetics, pediatric development, FISH analysis, copy number variation, aneuploidy, molecular diagnostics, absence of heterozygosity
Cite Scienmag News
Harold Sullivan. (November 17, 2026). SNP Microarray Clarifies Complex Mosaicism in Phenotypically Normal Male Infant. Scienmag. https://scienmag.com/snp-microarray-clarifies-complex-mosaicism-in-phenotypically-normal-male-infant/
Harold Sullivan. "SNP Microarray Clarifies Complex Mosaicism in Phenotypically Normal Male Infant." Scienmag, 17 November 2026, https://scienmag.com/snp-microarray-clarifies-complex-mosaicism-in-phenotypically-normal-male-infant/. Accessed 17 November 2026.
Harold Sullivan. "SNP Microarray Clarifies Complex Mosaicism in Phenotypically Normal Male Infant." Scienmag. November 17, 2026. https://scienmag.com/snp-microarray-clarifies-complex-mosaicism-in-phenotypically-normal-male-infant/








